Europe. Europe Legal Chronicle. July 21, 2021

Intellia Therapeutics’ Collaboration With Blackstone Life Sciences and Cellex Cell Professionals GmbH

By Federica Tiefenthaler

Hogan Lovells represented Intellia Therapeutics on the matter. Intellia Therapeutics launched a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company in a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here